Press release

Univercells receives grant from Walloon region to reduce the cost of vaccine manufacturing

Brussels, December 17, 2015

A grant of €466,500 ($509,500) was awarded to Univercells, following recommendations from the DG06 Economy, Employement and Research branch, to fund part of a two-year research project, UNIVERSCALE, to reduce the cost of vaccine manufacturing. It covers 70% of the budgeted costs of the industrial research part of the project.

The UNIVERSCALE project began in 2013 and is now in its final stages, to be completed by the end of 2015. It aims to secure proof of concept for the development of an integrated and continuous in-line manufacturing method for viral antigens (culture, expression and purification). The company’s goal is to reduce the cost of manufacturing vaccines by simplifying the production processes.

Company plans are to develop a highly productive biomanufacturing platform based on the results of the industrial research that the grant has funded.

download press release

  • Univercells reçoit une subvention de la Région wallonne pour réduire les coûts de fabrication des vaccins

    FR version

  • Univercells receives grant from Walloon region to reduce the costs of vaccine manufacturing

    EN Version

  • Univercells ontvangt subsidie van het Waalse Gewest voor de verlaging van de productiekost van vaccins

    NL version